Health panel approves coverage for iPS cell-derived Parkinson’s disease treatment
An advisory panel to the health minister on Wednesday approved Sumitomo Pharma’s Parkinson’s disease treatment Amchepry, which costs…
iPS cell-based products win conditional approval from health ministry panel
A health ministry panel has given conditional approval to two medical products derived from iPS cells, paving the…